Energy metabolism in human renin-gene transgenic rats: Does renin contribute to obesity?

Hypertension

Volumn 53, Issue 3, 2009, Pages 516-523

  Gratze, Petra ^c   Boschmann, Michael ^a,b,e   Dechend, Ralf ^c   Qadri, Fatimunnisa ^d   Malchow, Jeanette ^a   Graeske, Sabine ^a   Engeli, Stefan ^a   Janke, Jürgen ^a   Springer, Jochen ^f   Contrepas, Aurelie ^g   Plehm, Ralph ^d   Klaus, Susanne ^e   Nguyen, Genevieve ^g   Luft, Friedrich C ^a,d   Muller, Dominik N ^a,d  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Experimental and Clinical Research Center   (Germany)

^c HELIOS KLINIKUM BERLIN BUCH   (Germany)

^d MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^e GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^f DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^g INSERM   (France)

Author keywords

(Pro)renin receptor; Ace inhibitors; Handle region peptide; Metabolic syndrome; Obesity; Renin inhibitors; Renin angiotensin system

Indexed keywords

AGOUTI RELATED PROTEIN; AMPHETAMINE; APPETITE STIMULANT; COCAINE; MESSENGER RNA; NEUROPEPTIDE Y; PROOPIOMELANOCORTIN; RENIN; ALISKIREN; AMIDE; ANGIOTENSIN II; FUMARIC ACID DERIVATIVE; LEPTIN;

ADIPOCYTE; ANIMAL EXPERIMENT; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENERGY METABOLISM; GENE EXPRESSION; IN SITU HYBRIDIZATION; MALE; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; THERMOGENESIS; ANIMAL; BLOOD; CELL CULTURE; CYTOLOGY; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; HUMAN; LIPID METABOLISM; METABOLISM; PHENOTYPE; PHYSIOLOGY; SPRAGUE DAWLEY RAT; TRANSGENIC RAT;

ADIPOCYTES; AMIDES; ANGIOTENSIN II; ANIMALS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENERGY METABOLISM; FUMARATES; HUMANS; LEPTIN; LIPID METABOLISM; MALE; OBESITY; PHENOTYPE; RATS; RATS, SPRAGUE-DAWLEY; RATS, TRANSGENIC; RENIN; THERMOGENESIS;

EID: 61749094197     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.108.124966     Document Type: Article

References (27)

1. Kramer H. Obesity and chronic kidney disease. Contrib Nephrol. 2006; 151:1-18.
2. St-Pierre J, Lemieux I, Vohl MC, Perron P, Tremblay G, Despres JP, Gaudet D. Contribution of abdominal obesity and hypertriglyceridemia to impaired fasting glucose and coronary artery disease. Am J Cardiol. 2002;90:15-18.
3. Wilson PW, D'Agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med. 2002;162:1867-1872.
4. Bader M, Peters J, Baltatu O, Muller DN, Luft FC, Ganten D. Tissue renin-angiotensin systems: new insights from experimental animal models in hypertension research. J Mol Med. 2001;79:76-102.
5. Holness MJ, Sugden MC. The impact of genetic hypertension on insulin secretion and glucoregulatory control in vivo: studies with the TGR(m-Ren2)27 transgenic rat. J Hypertens. 1998;16:369-376.
6. Kinnick TR, Youngblood EB, O'Keefe MP, Saengsirisuwan V, Teachey MK, Henriksen EJ. Modulation of insulin resistance and hypertension by voluntary exercise training in the TG(mREN2)27 rat. J. Appl Physiol. 2002;93:805-812; discussion 797.
7. Uehara S, Tsuchida M, Kanno T, Sasaki M, Nishikibe M, Fukamizu A. Late-onset obesity in mice transgenic for the human renin gene. Int J Mol Med. 2003;11:723-727.
8. Lee MA, Bohm M, Paul M, Bader M, Ganten U, Ganten D. Physiological characterization of the hypertensive transgenic rat TGR(mREN2)27. Am J Physiol. 1996;270:E919-E929.
9. Takahashi N, Li F, Hua K, Deng J, Wang CH, Bowers RR, Baitness TJ, Kim HS, Harp JB. Increased energy expenditure, dietary fat wasting, and resistance to diet-induced obesity in mice lacking renin. Cell Metab. 2007;6:506-512.
10. Nguyen G, Delarue F, Burckle C, Bouzhir L, Giller T, Sraer JD. Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest. 2002;109:1417-1427.
11. Galvez-Prieto B, Bolbrinker J, Stucchi P, de Las Heras AI, Merino B, Arribas S, Ruiz-Gayo M, Huber M, Wehland M, Kreutz R, Fernandez-Alfonso MS. Comparative expression analysis of the renin-angiotensin system components between white and brown perivascular adipose tissue. J Endocrinol. 2008;197:55-64.
12. Feldt S, Batenburg WW, Mazak I, Maschke U, Wellner M, Kvakan H, Dechend R, Fiebeler A, Burckle C, Contrepas A, Jan Danser AH, Bader M, Nguyen G, Luft FC, Muller DN. Prorenin and renin-induced extracellular signal-regulated kinase 1/2 activation in monocytes is not blocked by aliskiren or the handle-region peptide. Hypertension. 2008;51:682-688.
13. Feldt S, Maschke U, Dechend R, Luft FC, Muller DN. The putative (pro)renin receptor blocker HRP fails to prevent (pro)renin signaling. J Am Soc Nephrol. 2008;19:743-748.
14. Ichihara A, Hayashi M, Kaneshiro Y, Suzuki F, Nakagawa T, Tada Y, Koura Y, Nishiyama A, Okada H, Uddin MN, Nabi AH, Ishida Y, Inagami T, Saruta T. Inhibition of diabetic nephropathy by a decoy peptide corresponding to the "handle" region for nonproteolytic activation of prorenin. J Clin Invest. 2004;114:1128-1135.
15. Ichihara A, Suzuki F, Nakagawa T, Kaneshiro Y, Takemitsu T, Sakoda M, Nabi AH, Nishiyama A, Sugaya T, Hayashi M, Inagami T. Prorenin receptor blockade inhibits development of glomerulosclerosis in diabetic angiotensin II type 1a receptor-deficient mice. J Am Soc Nephrol. 2006; 17:1950-1961.
16. Bohlender J, Fukamizu A, Lippoldt A, Nomura T, Dietz R, Menard J, Murakami K, Luft FC, Ganten D. High human renin hypertension in transgenic rats. Hypertension. 1997;29:428-434.
17. Ganten D, Wagner J, Zeh K, Bader M, Michel JB, Paul M, Zimmermann F, Ruf P, Hilgenfeldt U, Ganten U, Kaling M, Bachmann S, Fukamizu A, Mullins J, Murakami K. Species specificity of renin kinetics in transgenic rats harboring the human renin and angiotensinogen genes. Proc Natl Acad Sci U S A. 1992;89:7806-7810.
18. Wiedmer P, Boschmann M, Klaus S. Gender dimorphism of body mass perception and regulation in mice. J Exp Biol. 2004;207:2859-2866.
19. Aust L, Dongowski G, Frenz U, Taufel A, Noack R. Estimation of available energy of dietary fibres by indirect calorimetry in rats. Eur J Nutr. 2001;40:23-29.
20. Janke J, Schupp M, Engeli S, Gorzelniak K, Boschmann M, Sauma L, Nystrom FH, Jordan J, Luft FC, Sharma AM. Angiotensin type 1 receptor antagonists induce human in-vitro adipogenesis through peroxisome proliferator-activated receptor-gamma activation. J Hypertens. 2006;24: 1809-1816.
21. Leibel RL, Rosenbaum M, Hirsch J. Changes in energy expenditure resulting from altered body weight. N Engl J Med. 1995;332:621-628.
22. Boschmann M, Steiniger J, Franke G, Birkenfeld AL, Luft FC, Jordan J. Water drinking induces thermogenesis through osmosensitive mechanisms. J Clin Endocrinol Metab. 2007;92:3334-3337.
23. Boschmann M, Steiniger J, Hille U, Tank J, Adams F, Sharma AM, Klaus S, Luft FC, Jordan J. Water-induced thermogenesis. J Clin Endocrinol Metab. 2003;88:6015-6019.
24. Ando K, Fujita T. Anti-diabetic effect of blockade of the renin-angiotensin system. Diabetes Obes Metab. 2006;8:396-403.
25. Araki K, Masaki T, Katsuragi I, Tanaka K, Kakuma T, Yoshimatsu H. Telmisartan prevents obesity and increases the expression of uncoupling protein 1 in diet-induced obese mice. Hypertension. 2006;48:51-57.
26. Masaki T, Chiba S, Yasuda T, Tsubone T, Kakuma T, Shimomura I, Funahashi T, Matsuzawa Y, Yoshimatsu H. Peripheral, but not central, administration of adiponectin reduces visceral adiposity and upregulates the expression of uncoupling protein in agouti yellow (Ay/a) obese mice. Diabetes. 2003;52:2266-2273.
27. Archer ZA, Rayner DV, Mercer JG. Hypothalamic gene expression is altered in underweight but obese juvenile male Sprague-Dawley rats fed a high-energy diet. J Nutr. 2004;134:1369-1374.